Adeliz Figueroa Maldonado, AUDILOGIST Audiologist Medicare: Accepting Medicare Assignments Practice Location: Urb Baralt I 20, Fajardo, PR 00738 Phone: 787-860-4233 Fax: 787-292-5050 |
Eugenio Gomez Garcia Audiologist Medicare: Accepting Medicare Assignments Practice Location: Avenida Principal, Urb. Baralt I-28, Fajardo, PR 00738 Phone: 787-766-4623 |
News Archive
Alphabet Inc.'s Verily Life Sciences unit has come up with a plan to release around 20 million bacteria-filled engineered mosquitoes in Fresno, California. These are male mosquitoes that have been reared by machines and the campaign begins this Friday.
Seaside Therapeutics LLC today announced the issuance of U.S. patent 7,648,993 B2 (‘993 patent), which covers methods of treating autism with group 1 antagonists of the metabotropic glutamate receptor (mGluR) pathway. An earlier related patent, U.S. patent 6,890,931 B2 (‘931 patent), was issued in 2005 and covers methods of treating Fragile X Syndrome, the most common known cause of autism, with group 1 antagonists of the mGluR pathway.
Giving nitrous oxide as part of general anesthesia for noncardiac surgery doesn't increase the rate of complications and death—and might even decrease the risk of such events, according to a pair of studies in the May issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
Patients simultaneously treated for both Type 2 diabetes and depression improve medication compliance and significantly improve blood sugar and depression levels compared to patients receiving usual care, according to a new study by researchers from the Perelman School of Medicine at the University of Pennsylvania.
HeartWare International, Inc. announced today its intention to offer, subject to market and other conditions, $100 million principal amount of convertible senior notes due 2017 (the "notes") pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission ("SEC") today. HeartWare also intends to grant the underwriters an option to purchase up to an additional $15 million principal amount of notes to cover over-allotments, if any.
› Verified 3 days ago